实验猴涨价推动昭衍新药业绩反转,预计2025年扣非净利同比增长超9倍

每日经济新闻
Jan 26

1月21日,昭衍新药发布了2025年度业绩预告。公司预计实现营业收入约15.73亿元到17.38亿元,较2024年减少约13.9%到22.1%;实现净利润约2.33亿元到3.49亿元,较2024年增加约214%到371%;实现扣非净利润2.46亿元到3.70亿元,较2024年增加约945.2%到1467.7%。  公告显示,由于价格上涨叠加自身自然生长增值,2025年昭衍新药所持的生物资产的市场...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10